Business
Why has the Kazia Therapeutics (ASX:KZA) share price skyrocketed 80% in 1 month?
The Kazia Therapeutics Ltd (ASX: KZA) share price is one of the best performers on the ASX this past month, almost doubling in value before retreating today by 12% to $1.53. Overall, the drugmaker’s share price has gained over 82% during the past month of trading.
Why the big rise in the Kazia share price
Kazia is a Sydney-based, oncology-focused biotechnology drugmaker. The company’s flagship is the paxalisib drug used for the treatment of glioblastoma, which is the most common and aggressive form of primary brain cancer. The Kazia share price has risen strongly on the back of the ongoing and promising development of this particular drug.
In August, paxalisib was granted a fast track designation (FTD) by the United…
-
General15 hours agoAsia stocks plunge, HK suffers steepest fall since 1997
-
Noosa News20 hours agoDistress call sparks rescue operation for capsized sailor near North Stradbroke Island
-
Business20 hours agoBell Potter names more of the best ASX 200 stocks to buy in April
-
Noosa News19 hours agoTeenager sentenced to 12 years for ‘heinous’ Acacia Ridge murder